Invicta Diagnostic IPO
Invicta Diagnostic IPO
Overview
Invicta Diagnostic IPO is a book build issue of ₹28.12 crores. The issue is entirely a fresh issue of 0.33 crore shares of ₹28.12 crore. Invicta Diagnostic IPO bidding opened for subscription on Dec 1, 2025 and will close on Dec 3, 2025. The allotment for the Invicta Diagnostic IPO is expected to be finalized on Dec 4, 2025. Invicta Diagnostic IPO will list on NSE SME with a tentative listing date fixed as Dec 8, 2025. Invicta Diagnostic IPO price band is set at ₹80.00 to ₹85.00 per share . The lot size for an application is 1,600. The minimum amount of investment required by an individual investor (retail) is ₹2,72,000.00 (3,200 shares) (based on upper price). The minimum lot size investment for HNI is 3 lots (4,800 shares), amounting to ₹4,08,000. Socradamus Capital Pvt.Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Nikunj Stock Brokers Ltd..
Total Shares
33,08,800
Issue Size
₹28.12 Cr
Price Band
₹80 – ₹85
Lot Size
1600 shares
Min. Investment
₹2,72,000
Max. Investment
₹2,72,000
Open Date
01 Dec, 2025
Close Date
03 Dec, 2025
Allotment
04 Dec, 2025
Listing
08 Dec, 2025
Max. Investment
₹2,72,000
Announced
01 Dec, 2025
Opening Date
01 Dec, 2025
Closing Date
03 Dec, 2025
Basis of Allotment
04 Dec, 2025
Initiation of Refunds
05 Dec, 2025
Credit of Shares
05 Dec, 2025
Listing Date
08 Dec, 2025
Apply via UPI in 5 minutes
Choose your broker • Zero commission on IPO
About Invicta Diagnostic IPO
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. The company provides pathology and radiology testing, including imaging, radiology, and teleradiology, under the brand 'PC Diagnostics' through 7 diagnostic centres and a central laboratory across Mumbai, Maharashtra.
Invicta Diagnostics Limited (trading as PC Diagnostics) is a Mumbai-based diagnostic services company specialising in integrated pathology and radiology solutions. The c
Invicta Diagnostic IPO Share Price
Issue Breakdown
Shareholding
Dilution: 35.7% increase in shares
Invicta Diagnostic IPO Promoters Holding
Invicta Diagnostic IPO Financial Health
Invicta Diagnostic Ltd.'s revenue increased by 90% and profit after tax (PAT) rose by 30% between the financial year ending with March 31, 2025 and March 31, 2024.
Invicta Diagnostic IPO Lot Size
Investors can bid for a minimum of 3,200 shares and in multiples of 1,600 shares thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 3200 | ₹2,72,000 |
| Individual investors (Retail) (Max) | 2 | 3200 | ₹2,72,000 |
| S-HNI (Min) | 3 | 4800 | ₹4,08,000 |
| S-HNI (Max) | 7 | 11200 | ₹9,52,000 |
| B-HNI (Min) | 8 | 12800 | ₹10,88,000 |
(All values in CR)
Invicta Diagnostic IPO Valuations
KPI as of Mon, Mar 31, 2025.
| Metric | Value |
|---|---|
| ROE | 44.28 |
| ROCE | 42.00 |
| Debt/Equity | 0.26 |
| RoNW | 36.25 |
| PAT Margin | 16.38 |
| EBITDA Margin | 30.57 |
| Price to Book Value | 5.26 |
| Market Capitalization | 106.86 |
(All values in CR)
Invicta Diagnostic IPO Strength & Risk
Invicta Diagnostic IPO Strength:
- Operates in the healthcare diagnostics sector, which has steady and growing demand.
- Provides a range of diagnostic services, improving revenue diversification.
- Benefits from increasing awareness of preventive healthcare and wellness testing.
- Focuses on accuracy, quality, and timely reporting, enhancing customer trust.
- Potential to scale operations through new centres, partnerships, and technology adoption.
- Asset-light expansion model can support faster growth with controlled costs.
- Growing acceptance of digital health platforms supports online booking and report delivery.
Invicta Diagnostic IPO Risk:
- Faces strong competition from established national and regional diagnostic chains.
- Dependent on skilled medical professionals, technicians, and advanced equipment.
- Subject to regulatory compliance, accreditation norms, and healthcare quality standards.
- Vulnerable to fluctuations in test volumes due to seasonal variations or economic trends.
- Sensitive to pricing pressure as consumers often compare rates across diagnostics providers.
- High reliance on machinery and technology increases maintenance and upgrade requirements.
- As an SME IPO, post-listing liquidity may be limited, increasing volatility risk.
Invicta Diagnostic IPO Subscriptions Status
Invicta Diagnostic IPO subscribed 0.95 times. The public issue subscribed 0.79 times in the individual investors category, 1.55 times in QIB (Ex Anchor), and 0.74 times in the NII category by December 2, 2025 6:14:59 PM (Day 2).
| Investor Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Rs Cr.) |
|---|---|---|---|---|
| Anchor | 1.00 | 7,98,400 | 7,98,400 | 6.786 |
| Market Maker | 1.00 | 1,66,400 | 1,66,400 | 1.414 |
| QIB (Ex Anchor) | 1.55 | 5,34,400 | 8,28,800 | 7.045 |
| Non-Institutional Buyers | 0.74 | 5,42,400 | 4,00,000 | 3.4 |
| bNII (bids above ₹10L) | 0.81 | 3,61,600 | 2,94,400 | 2.502 |
| sNII (bids below ₹10L) | 0.58 | 1,80,800 | 1,05,600 | 0.898 |
| Individual Investors (IND category bidding for 2 Lots) | 0.79 | 12,67,200 | 10,04,800 | 8.541 |
| Total | 0.95 | 23,44,000 | 22,33,600 | 18.986 |
Invicta Diagnostic IPO GMP
Invicta Diagnostic SME IPO last GMP is ₹0, last updated Dec 2nd 2025 05:28 PM. With the price band of 85.00, Invicta Diagnostic SME IPO's estimated listing price is ₹85 (cap price + today's GMP).The expected percentage gain/loss per share is 0.00%.
Last updated 02 Dec, 2025 · Source: aggregated grey-market dealers
| Date | IPO Price | GMP | Sub2 Sauda | Est. Listing | Est. Profit | Updated |
|---|---|---|---|---|---|---|
| 02 Dec, 2025 | 85 | ₹0 | - | ₹85 (0.00%) | - | 02 Dec, 2025 |
| 01 Dec, 2025 | 85 | ₹0 | - | ₹85 (0.00%) | - | 01 Dec, 2025 |
| 30 Nov, 2025 | 85 | ₹0 | - | ₹85 (0.00%) | - | 30 Nov, 2025 |
| 29 Nov, 2025 | 85 | ₹0 | - | ₹85 (0.00%) | - | 29 Nov, 2025 |
| 28 Nov, 2025 | 85 | ₹0 | - | ₹85 (0.00%) | - | 28 Nov, 2025 |
| 27 Nov, 2025 | 85 | ₹0 | - | ₹85 (0.00%) | - | 27 Nov, 2025 |
| 26 Nov, 2025 | 85 | ₹0 | - | ₹85 (0.00%) | - | 26 Nov, 2025 |
| 25 Nov, 2025 | 85 | ₹0 | - | ₹85 (0.00%) | - | 25 Nov, 2025 |
Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.
How to Apply for Invicta Diagnostic IPO
Login to Your Trading App
Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.
Go to IPO Section
Find Invicta Diagnostic IPO under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).
Enter UPI ID and Submit
Provide your UPI ID linked to your bank account and submit the application.
Approve Mandate on UPI App
Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.
Application Confirmed
Your funds will be blocked in your account until the IPO allotment process is completed.